H Kim

Latest

• Identifying therapeutic targets in low‐grade serous ovarian carcinomas with no specific molecular profile
• Multiomics Characterization of Low-grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK-inhibitor Sensitivity and Therapeutic Vulnerability